These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 17360039

  • 1. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
    Alvarez CA, Wiederhold NP, McConville JT, Peters JI, Najvar LK, Graybill JR, Coalson JJ, Talbert RL, Burgess DS, Bocanegra R, Johnston KP, Williams RO.
    J Infect; 2007 Jul; 55(1):68-74. PubMed ID: 17360039
    [Abstract] [Full Text] [Related]

  • 2. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
    Rieg G, Spellberg B, Schwartz J, Fu Y, Edwards JE, Sheppard DC, Ibrahim AS.
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
    [No Abstract] [Full Text] [Related]

  • 3. In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis.
    Hoeben BJ, Burgess DS, McConville JT, Najvar LK, Talbert RL, Peters JI, Wiederhold NP, Frei BL, Graybill JR, Bocanegra R, Overhoff KA, Sinswat P, Johnston KP, Williams RO.
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1552-4. PubMed ID: 16569882
    [Abstract] [Full Text] [Related]

  • 4. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
    Takemoto K, Yamamoto Y, Ueda Y, Sumita Y, Yoshida K, Niki Y.
    J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
    [Abstract] [Full Text] [Related]

  • 5. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
    Chen J, Li H, Li R, Bu D, Wan Z.
    J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
    [Abstract] [Full Text] [Related]

  • 6. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE, Prince RA, Chi J, Kontoyiannis DP.
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
    [Abstract] [Full Text] [Related]

  • 7. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
    Petraitiene R, Petraitis V, Groll AH, Sein T, Piscitelli S, Candelario M, Field-Ridley A, Avila N, Bacher J, Walsh TJ.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
    [Abstract] [Full Text] [Related]

  • 8. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis.
    Kaur S, Gupta VK, Thiel S, Sarma PU, Madan T.
    Clin Exp Immunol; 2007 May; 148(2):382-9. PubMed ID: 17335555
    [Abstract] [Full Text] [Related]

  • 9. Histopathology of experimental invasive pulmonary aspergillosis in rats: pathological comparison of pulmonary lesions induced by specific virulent factor deficient mutants.
    Shibuya K, Takaoka M, Uchida K, Wakayama M, Yamaguchi H, Takahashi K, Paris S, Latge JP, Naoe S.
    Microb Pathog; 1999 Sep; 27(3):123-31. PubMed ID: 10455003
    [Abstract] [Full Text] [Related]

  • 10. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
    Manavathu EK, Cutright JL, Chandrasekar PH.
    Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis.
    Chiang LY, Ejzykowicz DE, Tian ZQ, Katz L, Filler SG.
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3464-6. PubMed ID: 17005833
    [Abstract] [Full Text] [Related]

  • 12. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis.
    Mehrad B, Strieter RM, Standiford TJ.
    J Immunol; 1999 Feb 01; 162(3):1633-40. PubMed ID: 9973423
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
    Nagasaki Y, Eriguchi Y, Uchida Y, Miyake N, Maehara Y, Kadowaki M, Harada M, Akashi K, Shimono N.
    J Antimicrob Chemother; 2009 Aug 01; 64(2):379-82. PubMed ID: 19465436
    [Abstract] [Full Text] [Related]

  • 14. Disseminated invasive aspergillosis in an apparently immunocompetent host.
    Raja NS, Singh NN.
    J Microbiol Immunol Infect; 2006 Feb 01; 39(1):73-7. PubMed ID: 16440127
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
    Kirkpatrick WR, Najvar LK, Vallor AC, Wiederhold NP, Bocanegra R, Pfeiffer J, Perkins K, Kugler AR, Sweeney TD, Patterson TF.
    J Antimicrob Chemother; 2012 Apr 01; 67(4):970-6. PubMed ID: 22240402
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals.
    Ho KM, Duff O, Chambers D, Murray R.
    Transpl Infect Dis; 2008 Jun 01; 10(3):168-76. PubMed ID: 18194368
    [Abstract] [Full Text] [Related]

  • 17. Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.
    van de Sande WW, van Vianen W, ten Kate MT, Vissers J, Laurijsens J, Tavakol M, Rijnders BJ, Mathot RA, Bakker-Woudenberg IA.
    Antimicrob Agents Chemother; 2008 Apr 01; 52(4):1345-50. PubMed ID: 18195059
    [Abstract] [Full Text] [Related]

  • 18. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D, Bassaris H, McGeer A, Arthur C, Prentice HG, Seifert W, De Beule K.
    Clin Infect Dis; 2001 Oct 15; 33(8):e83-90. PubMed ID: 11550120
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
    Allendoerfer R, Loebenberg D, Rinaldi MG, Graybill JR.
    Antimicrob Agents Chemother; 1995 Jun 15; 39(6):1345-8. PubMed ID: 7574528
    [Abstract] [Full Text] [Related]

  • 20. Multidrug resistance in Aspergillus fumigatus.
    Warris A, Weemaes CM, Verweij PE.
    N Engl J Med; 2002 Dec 26; 347(26):2173-4. PubMed ID: 12501236
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.